Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just like death on DCVax. Inevitable.
Considering he is a known liar about NWBO data whom Liau had to correct. He used to always pass off pseudoprogressors as rapid progressors in the information arm presentations he gave and then when Liau gave them she said they were pseudoprogressors. Gee, giving DCVax to a bunch of pseudoprogressors and calling them rapid progressors makes DCVax look like it actually does something.
I think you meant "excuses", not "options". I guess for screwing shareholders she has many options. Nobody thought after she screwed shareholders by building out and selling Cognate that she would do it again and here you are paying for Advent to be LPs personal piggy bank.
Are you familiar with the drug approval process? It's not done with a 10 person trial of mixed indication patients.
There are a million tiny trials where the results are stunning. And then they never hold up in large trials because of the selection bias. They fail with a properly powered RCT like the DCVax P3 did. Wipe the breadcrumbs from your eyes.
What does anything you are babbling about have to do with the constant bashing of Optune when the same authors are found on both papers.
Again focus your response on what I said. Don't babble. If an oncologist contributed to the JAMA Optune paper and you all claim they are quacks and have actively sought to character assassinate them. then please admit you are hypocrites or just lying about oncologists who are not shills for NWBO.
So the author list is the end all, be all and means the treatment must work? Yet some of the same authors were on authors on the Optune paper which you idiots swear doesn't work even though it was approved. Which is it? Doctors want their names on papers. Papers of proven treatments AND failed treatments that never get approved.
https://jamanetwork.com/journals/jama/fullarticle/2666504
Roger Stupp, MD1,2,3; Sophie Taillibert, MD4; Andrew Kanner, MD5; William Read, MD6,7; David M. Steinberg, PhD8; Benoit Lhermitte, MD2; Steven Toms, MD9; Ahmed Idbaih, MD4; Manmeet S. Ahluwalia, MD10; Karen Fink, MD, PhD11; Francesco Di Meco, MD12; Frank Lieberman, MD13; Jay-Jiguang Zhu, MD, PhD14,15; Giuseppe Stragliotto, MD, PhD16; David D. Tran, MD, PhD17; Steven Brem, MD18,19; Andreas F. Hottinger, MD, PhD2; Eilon D. Kirson, MD, PhD20; Gitit Lavy-Shahaf, PhD20; Uri Weinberg, MD, PhD20; Chae-Yong Kim, MD, PhD21; Sun-Ha Paek, MD, PhD22; Garth Nicholas, MD23; Jordi Bruna, MD24; Hal Hirte, MD25; Michael Weller, MD3; Yoram Palti, MD, PhD20; Monika E. Hegi, PhD2; Zvi Ram, MD5
Yes. My position is clear on the paper. Why aren't they all recommending their patients go to the UK for the excellent specials program that treats maybe 2 patients a year? What about the authors in the JAMA article that were also authors on the Optune paper that resulted in an actual approved treatment?
The majority of those listed on the JAMA paper are contributors, not authors, and have no other credits to their name. Because they were most likely an assistant who wrote up when the patient died.
Most oncologists understand the trial didn't prove shit because it was poorly designed, run, and changed after everyone was treated and the majority of patients died.
50% of total GBM patients were not represented in the trial based on inclusion/exclusion criteria so why would you assume 50% penetration? Even if one believed the numbers against a real control arm and not the bullshit ECA, the trial represented GBM patients with the best prognosis. Less than 30% total GBM population. And of those, the benefit is miniscule. Who do you think will pay for this? Not the MHRA.
So yeah, your numbers are pie in the sky bullshit. Might as well claim all of the UK population will get it for the prophylactic effect.
Those that thought this would go to $20 on approval when the OS was 100 million still think it will happen when the OS is approaching 2 billion. Math is hard I guess.
You should really research before opening your mouth.
https://www.adventbio.uk/post/customer-feedback-pepgen
https://www.adventbio.uk/post/customer-feedback-mesobank
I am sure there are many more that don't provide written feedback and just use the services of Advent.
Cognate is relevant because idiots like flipper for years posted job announcements, shipping labels, linkedin blurbs and other useless garbage trying to tie it to approval and yet nothing happened.
It's a shame the internet doesn't work over the ocean. I'm still waiting for my raven to return with my MHRA FOIA request.
Yes. CDMOs have clients. Advent has multiple for whom they create a products. Cognate had a head of Engineering and Facilities too. Both nothing to do with this POS.
No. If they did they are obviously deceased as nobody has heard anything from them. Thats usually bad news when you are hyping a treatment.
Polaroid had a ton of patents.
Outlive a death sentence? 331 patients in the trial with the vast majority deceased is not “outliving a death sentence”.
278 of 331 patients didn’t make it 4 years. And that’s from a highly selective patient population.
Everyone knows the endpoint was changed because of the futility recommendation based on the company’s own protocol.
Why is the company hiding the control arm data?
Probably that NWBO shareholders can fund yet another company of which they will see no benefit. Just like Cognate and Advent. Call it the LP Sucker Trifecta
You are calling someone dumb? Neither the delusional longs nor the shills on this board like you and you don't realize it.
Same bullshit was spouted about CUSIP changes on every penny stock board since Ihub has been a thing. It does nothing. The only benefit to NWBO of a CUSIP change would be to change the name of the company and bury all the shady ass things they've done while trying to sell a placebo as a viable treatment for the last 20 years.
Cool. A 65 page PDF of irrelevance.
"fool me twice"
And for every one of those, there are 100 NWBOs that milk shareholders dry, make their money off inflated salaries, selling shares, and having no product, and then sitting in OTC pennystock purgatory for the rest of their existence.
To be fair one doesn't need a salesforce if they never have anything to sell but your point is certainly valid for legitimate companies.
You're welcome for my posts. And the reason many are here is because of the shilling of the senti's, flippers, ATLs and the many others who got buried by paper debt and don't even consider the opportunity cost of watching their paper holdings deteriorate for 10+years.
My "games" have nothing to do with the company's silence as they used to pump out weekly PRs. My "games" come from the blatant lying by the company, the withholding information, the lack of transparency, blaming everyone but themselves for the failure as a publicly traded company, and the inability for them to admit something as simple and devastating to the stock and company as the futility recommendation. I could rehash Bosch's many lies regarding pseudoprogression that were contradicted and corrected by Liau, but that scheister is still an officer of the company. So he will always lie if a microphone is in front of him.
They still don't file properly and ignore the basic rules of being a publicly traded company.
It's a scam. LP is laughing all the way to the bank. Advent sale coming soon.
Advent has paying clients that it actually produces products for and makes money off of them.
LP poured NWBO money into Cognate. How'd that work out? Great for LP.
People posts walls of bullshit text regularly too. You do it almost every time you post.
i didn't write anything that was false, asshole.
They actually ran a successful, well designed trial, proved the combo worked, and submitted those results for approval with the FDA like a normal company does.
Yeah I'm colluding with AF dumbass. He blocked me long ago.
The company NEVER followed up on any promise and it was evident after about the first 3 PRs. Once they screwed their only institutional investor EVER the market knew it was a P&D scheme too and traded it accordingly. Typical for a biotech with no valid product.
Let me know when you learn how to make money in the stock market.
Nahh, I actually made money on this before it was a POS OTC penny stock. I don't think anyone else who posts on this board has unless they short it.
1) Find scam
2) Observe scam trading patterns
3) trade like the scammer
4) profit!
Yep. I've actually been treated for cancer with an approved treatment. It's very personal, someone scamming cancer patients and their families.
Buying more because of some random comment on a message board is about as good of an investment strategy as every long bagholder here. Congrats.
The first 20 would be flipper connecting dots.
I bailed from the stock after I made money since this P&D was so easy to time fopr buying and selling. I'll badmouth them as long as they keep taking advantage of cancer patients.
Tomorrow he's buying the 1.1 billion float.
How dare you EVER having ignored me! 🤣
I'm guessing waiting 10 more years on a trial that failed in 2014.